Literature DB >> 4988841

The action of L-dopa on schizophrenic patients (a preliminary report).

J A Yaryura-Tobias, B Diamond, S Merlis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4988841

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN： 0011-393X


× No keyword cloud information.
  10 in total

1.  Schizophrenia: a theory.

Authors:  E Hartmann
Journal:  Psychopharmacology (Berl)       Date:  1976-08-26       Impact factor: 4.530

2.  The effect of L-dopa on young patients with simple schizophrenia, treated with neuroleptic drugs: a double-blind cross-over trial with Madopar and placebo.

Authors:  J Gerlach; K Lühdorf
Journal:  Psychopharmacologia       Date:  1975-10-14

Review 3.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

4.  Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa.

Authors:  R J Hardie; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

5.  Apomorphine and psychopathology.

Authors:  S Lal; C E De la Vega
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-07       Impact factor: 10.154

6.  Antagonism by haloperidol of the L-DOPA-induced disruption of a successive discrimination in the rat.

Authors:  S Ahlenius; J Engel
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

Review 7.  A meta-analysis of the response to chronic L-dopa in patients with schizophrenia: therapeutic and heuristic implications.

Authors:  George E Jaskiw; Anand P Popli
Journal:  Psychopharmacology (Berl)       Date:  2003-12-11       Impact factor: 4.530

Review 8.  Epilepsy and schizophrenia: a neurochemical bridge.

Authors:  F Lamprecht
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

9.  Clinical and [123I]FP-CIT SPET imaging follow-up in patients with drug-induced parkinsonism.

Authors:  Michele Tinazzi; Angelo Antonini; Tommaso Bovi; Isabella Pasquin; Maria Steinmayr; Giuseppe Moretto; Antonio Fiaschi; Sarah Ottaviani
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

Review 10.  Dopamine and psychosis: theory, pathomechanisms and intermediate phenotypes.

Authors:  Heike Tost; Tajvar Alam; Andreas Meyer-Lindenberg
Journal:  Neurosci Biobehav Rev       Date:  2009-06-24       Impact factor: 8.989
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.